Transgenic Mouse Model for Human Serum Amyloid A in Adipose Tissue
Author Information
Author(s): Maja Olsson, Sofie Ahlin, Bob Svensson, Per-Arne Ståhlman, Marcus Borén, Jan Carlsson, Lena M. S. Sjöholm, Kajsa Sahlgrenska
Primary Institution: Sahlgrenska Center for Cardiovascular and Metabolic Research, Institute of Medicine at the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Hypothesis
The study aims to clarify the role of adipocyte-derived serum amyloid A (SAA) in obesity by establishing a transgenic mouse model expressing human SAA in adipose tissue.
Conclusion
The transgenic mouse model demonstrates that adipose tissue-produced human SAA enters the circulation, resulting in elevated plasma levels similar to those observed in humans.
Supporting Evidence
- Transgenic mice showed specific expression of human SAA in adipose tissue.
- Plasma levels of human SAA were significantly higher in high-fat diet fed mice compared to normal chow fed mice.
- The established model mirrors the SAA phenotype seen in human obesity.
Takeaway
Scientists created special mice that produce a protein called SAA in their fat, which helps them study how this protein affects obesity and related health problems.
Methodology
The study involved creating a transgenic mouse model and analyzing gene expression, body composition, and plasma levels of SAA after feeding different diets.
Limitations
The study primarily focuses on male mice, which may limit the generalizability of the findings to females.
Participant Demographics
Male transgenic mice on a C57BL/6J background were used in the study.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website